Joshua D. Grill - Publications

2004 Wake Forest University School of Medicine, Winston-Salem, NC, United States 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chang TS, Teng E, Elashoff D, Grill JD. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Disease and Associated Disorders. PMID 27196535 DOI: 10.1097/Wad.0000000000000150  0.48
2016 Grill JD, Zhou Y, Elashoff D, Karlawish J. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiology of Aging. 39: 147-53. PMID 26923411 DOI: 10.1016/J.Neurobiolaging.2015.11.007  0.48
2015 Grill JD, Karlawish J. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Disease and Associated Disorders. 29: 364. PMID 26485500 DOI: 10.1097/Wad.0000000000000109  0.48
2015 Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimer's Research & Therapy. 7: 43. PMID 26120369 DOI: 10.1186/S13195-015-0127-0  0.48
2015 Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/S13195-015-0122-5  0.48
2015 Grill JD, Vinters HV, Monsell SE. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Disease and Associated Disorders. PMID 25973910 DOI: 10.1097/Wad.0000000000000092  0.48
2015 Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimer's Research & Therapy. 7: 26. PMID 25969699 DOI: 10.1186/S13195-015-0112-7  0.48
2015 Jennings LA, Reuben DB, Evertson LC, Serrano KS, Ercoli L, Grill J, Chodosh J, Tan Z, Wenger NS. Unmet needs of caregivers of individuals referred to a dementia care program. Journal of the American Geriatrics Society. 63: 282-9. PMID 25688604 DOI: 10.1111/Jgs.13251  0.48
2015 Hsiao JJ, Lu PH, Grill JD, Teng E. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 39: 12-24. PMID 25300404 DOI: 10.1159/000365587  0.48
2015 Cary MS, Rubright JD, Grill JD, Karlawish J. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Disease and Associated Disorders. 29: 70-4. PMID 24805971 DOI: 10.1097/Wad.0000000000000047  0.48
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease Alzheimer's Research and Therapy. 7. DOI: 10.1186/s13195-015-0135-0  0.48
2014 Grill JD, Zhou Y, Karlawish J, Elashoff D. Frequency and Impact of Informant Replacement in Alzheimer Disease Research. Alzheimer Disease and Associated Disorders. PMID 25551863 DOI: 10.1097/Wad.0000000000000078  0.48
2014 Grill JD, Galvin JE. Facilitating Alzheimer disease research recruitment. Alzheimer Disease and Associated Disorders. 28: 1-8. PMID 24322484 DOI: 10.1097/Wad.0000000000000016  0.48
2014 Grill JD, Monsell SE. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiology of Aging. 35: 466-71. PMID 24119546 DOI: 10.1016/J.Neurobiolaging.2013.09.001  0.48
2014 Grill JD, Zhou Y, Karlawish J, Elashoff D. Does study partner type impact the rate of Alzheimer's disease progression? Journal of Alzheimer's Disease : Jad. 38: 507-14. PMID 23985417 DOI: 10.3233/Jad-131052  0.48
2013 Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage. Clinical. 2: 827-35. PMID 24179834 DOI: 10.1016/J.Nicl.2013.05.007  0.48
2013 Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemporary Clinical Trials. 36: 256-62. PMID 23876673 DOI: 10.1016/J.Cct.2013.07.006  0.48
2013 Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 80: 282-8. PMID 23255824 DOI: 10.1212/Wnl.0B013E31827Debfe  0.48
2013 Grill JD, Karlawish J, Elashoff D, Vickrey BG. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 356-359.e1. PMID 23141383 DOI: 10.1016/J.Jalz.2012.03.001  0.48
2013 Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging. 34: 62-72. PMID 22503160 DOI: 10.1016/J.Neurobiolaging.2012.03.006  0.48
2012 Grill JD, Monsell S, Karlawish J. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dementia and Geriatric Cognitive Disorders. 33: 334-40. PMID 22759982 DOI: 10.1159/000339361  0.48
2012 Grill JD, Cummings J. Alzheimer’s disease Clinical Trials in Neurology: Design, Conduct, Analysis. 227-241. DOI: 10.1017/CBO9781139032445.022  0.48
2011 Grill JD, Ringman JM. Should persons with autosomal dominant AD be included in clinical trials? Alzheimer's Research & Therapy. 3: 18. PMID 21609419 DOI: 10.1186/Alzrt80  0.48
2010 Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 2: 34. PMID 21172069 DOI: 10.1186/Alzrt58  0.48
2010 Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 711-28. PMID 20420492 DOI: 10.1586/Ern.10.29  0.48
2009 Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 166-71. PMID 19328453 DOI: 10.1016/J.Jalz.2008.12.002  0.48
2007 Robinson-Smith G, Grill JD. Recognizing involuntary emotional expression disorder. The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses. 39: 202-7. PMID 17847666 DOI: 10.1097/01376517-200708000-00003  0.48
2005 Grill JD, Sonntag WE, Riddle DR. Dendritic stability in a model of adult-onset IGF-I deficiency. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 15: 337-48. PMID 16143551 DOI: 10.1016/J.Ghir.2005.07.002  0.48
2002 Grill JD, Riddle DR. Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Research. 937: 8-21. PMID 12020857 DOI: 10.1016/S0006-8993(02)02457-5  0.48
2002 Grill JD, Coghill RC. Transient analgesia evoked by noxious stimulus offset. Journal of Neurophysiology. 87: 2205-8. PMID 11929939 DOI: 10.1152/Jn.00730.2001  0.48
Show low-probability matches.